A study showed that JMJD6 demethylated the hepatocyte nuclear factor 4 alpha (Hnf4α) promoter and inhibited its expression in the absence of PRMT1 (55), whereas Hnf4α is identified as a tumor suppressor and therapeutic target in liver cancer (56). Here, HNF4A is linked to neoplasm.